Text Size
85 studies found for:    "Sham injection"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Completed A Phase 3 Study To Compare The Efficacy And Safety Of 0.3 MG Pegaptanib Sodium To Sham Injections In Subjects With Diabetic Macular Edema
Conditions: Macular Edema;   Diabetic Mellitus;   Retinal Disease
Interventions: Drug: pegaptanib sodium;   Other: sham injection
2 Completed
Has Results 		A Study of the Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Branch Retinal Vein Occlusion (BRAVO)
Conditions: Macular Edema;   Retinal Vein Occlusion
Interventions: Drug: Ranibizumab injection 0.3 mg;   Drug: Ranibizumab injection 0.5 mg;   Drug: Sham injection
3 Completed
Has Results 		A Study of the Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion (CRUISE)
Conditions: Macular Edema;   Retinal Vein Occlusion
Interventions: Drug: Sham injection;   Drug: Ranibizumab injection 0.3 mg;   Drug: Ranibizumab injection 0.5 mg
4 Completed A Multicenter Study to Compare Multiple Doses of Intravitreal Microplasmin Versus Sham Injection for Treatment of Patients With DME
Condition: Diabetic Macular Edema
Interventions: Drug: Microplasmin;   Other: Sham injection
5 Completed
Has Results 		Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy
Conditions: Proliferative Diabetic Retinopathy;   Diabetic Macular Edema
Interventions: Drug: Ranibizumab;   Drug: Triamcinolone Acetonide;   Behavioral: Sham injection;   Procedure: Focal/grid laser
6 Active, not recruiting Safety and Efficacy Study of Intravitreal Ocriplasmin in Subjects With AMD With Focal Vitreomacular Adhesion
Conditions: Exudative Age-Related Macular Degeneration;   Focal Vitreomacular Adhesion
Interventions: Drug: Ocriplasmin;   Drug: Sham injection
7 Recruiting Fluocinolone Acetonide Intravitreal Inserts in Geographic Atrophy
Condition: Age-Related Macular Degeneration
Interventions: Drug: Fluocinolone Acetonide;   Drug: Sham Injection
8 Recruiting Evaluation of CureXcell™ in Treating Lower Extremity Chronic Ulcers in Adults With Diabetes
Condition: Lower Extremity Chronic Ulcers in Diabetics
Interventions: Biological: Curexcell;   Biological: Sham injection
9 Active, not recruiting
Has Results 		A Study of Ranibizumab Injection in Subjects With Clinically Significant Macular Edema (ME) With Center Involvement Secondary to Diabetes Mellitus (RISE)
Conditions: Diabetes Mellitus;   Macular Edema
Interventions: Drug: Ranibizumab;   Drug: Sham injection
10 Active, not recruiting
Has Results 		A Study of Ranibizumab Injection in Subjects With Clinically Significant Macular Edema (ME) With Center Involvement Secondary to Diabetes Mellitus (RIDE)
Conditions: Diabetes Mellitus;   Macular Edema
Interventions: Drug: Ranibizumab;   Drug: Sham injection
11 Completed Vitamin A and Very Low Birthweight Babies (VitAL)
Conditions: Preterm Birth;   Retinopathy of Prematurity
Interventions: Drug: Aquasol A;   Drug: aquasol A;   Other: sham injection
12 Active, not recruiting Ocriplasmin for Treatment for Symptomatic Vitreomacular Adhesion / (VMT) Including Macular Hole
Condition: Vitreomacular Adhesion Including Macular Hole
Interventions: Drug: Ocriplasmin;   Other: Sham injection
13 Not yet recruiting Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal Insert
Conditions: Posterior Uveitis;   Intermediate Uveitis;   Panuveitis
Interventions: Drug: FAI insert;   Drug: Sham injection
14 Terminated A Multicenter, Proof-Of-Concept Study Of Intravitreal AL-78898A In Patients With Geographic Atrophy (GA) Associated With Age-Related Macular Degeneration (AMD)
Condition: Geographic Atrophy Related to Age-related Macular Degeneration
Interventions: Drug: Al-78898A;   Drug: Sham Injection
15 Completed Avastin for PDR (Proliferative Diabetic Retinopathy)
Conditions: Retinal Detachment;   Diabetic Retinopathy
Interventions: Drug: Avastin (bevacizumab);   Other: Sham injection
16 Recruiting A Randomized, Double-blind, Multicenter, Sham-controlled, Safety and Efficacy Study of Conbercept in Patients With mCNV
Condition: Choroid Neovascularization Secondary to Pathological Myopia
Interventions: Drug: conbercept, Fixed;   Drug: conbercept, PRN;   Other: sham injection
17 Active, not recruiting Darbepoetin Administration to Preterm Infants
Condition: Infant, Newborn
Interventions: Drug: darbepoetin alfa;   Drug: erythropoietin;   Drug: sham injection
18 Active, not recruiting A Randomized, Blinded, Multicenter Study to Evaluate NASHA/Dx for the Treatment of Fecal Incontinence
Condition: Fecal Incontinence
Interventions: Device: NASHA/Dx Injectable Gel;   Device: Sham Injection
19 Recruiting Ranibizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion in Patients With Fair Vision
Conditions: Branch Retinal Vein Occlusion;   Macular Edema
Interventions: Drug: Ranibizumab;   Device: Sham injection;   Procedure: Rescue laser
20 Terminated Chronic Post Breast Surgery Pain
Condition: Breast Cancer
Interventions: Procedure: Paravertebral block;   Procedure: Sham injections
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years